发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 4735 |
| CHINA MAINLAND | 1024 |
| Japan | 800 |
| England | 649 |
| Canada | 519 |
| France | 488 |
| GERMANY (FED REP GER) | 475 |
| Spain | 458 |
| Italy | 457 |
| South Korea | 361 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| UNIVERSITY OF CALIFORNIA SYSTEM | 665 |
| HARVARD UNIVERSITY | 391 |
| MAYO CLINIC | 343 |
| UNIVERSITY OF TEXAS SYSTEM | 313 |
| US DEPARTMENT OF VETERANS AFFAIRS | 264 |
| PENNSYLVANIA COMMONWEALTH SYSTEM OF HIG... | 260 |
| UNIVERSITY OF TORONTO | 256 |
| ASSISTANCE PUBLIQUE HOPITAUX PARIS (APH... | 253 |
| VIRGINIA COMMONWEALTH UNIVERSITY | 252 |
| UNIVERSITY OF LONDON | 251 |
文章引用情况
1
NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis2
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances3
Taurine up-regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma4
Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway5
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis6
Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma7
Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population8
Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice9
The high burden of alcoholic cirrhosis in privately insured persons in the United States10
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 000-patient 15-year experience